Albrecht, T., Braun, J. D., Qiu, J., Peters, V., Schmitt, C. P., Lammert, A., . . . Hauske, S. J. (2017). The CNDP1 (CTG)5 polymorphism is associated with biopsy-proven diabetic nephropathy, time on hemodialysis, and diabetes duration. Journal of diabetes research, 2017, . https://doi.org/10.1155/2017/9506730
Chicago-Zitierstil (17. Ausg.)Albrecht, Thomas, et al. "The CNDP1 (CTG)5 Polymorphism Is Associated with Biopsy-proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration." Journal of Diabetes Research 2017 (2017). https://doi.org/10.1155/2017/9506730.
MLA-Zitierstil (9. Ausg.)Albrecht, Thomas, et al. "The CNDP1 (CTG)5 Polymorphism Is Associated with Biopsy-proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration." Journal of Diabetes Research, vol. 2017, 2017, https://doi.org/10.1155/2017/9506730.